iiinova — where your digital self keeps evolving

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 13/08/2026

A Review led by the Yale Breast team highlights that #TNBC is not one disease. Rare histologic subtypes have distinct biology & clinical behavior. Combining histology with molecular profiling could help advance more personalized care. nature.com/articles/s41... @maryamlustberg.bsky.social

011

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 25/03/2026

We invite physicians, APPs, and nurses to join us Wed. April 8 at 6pm for a free networking and CME dinner on women's health and #breastcancer. ➡️Presenters: Drs. @maryamlustberg.bsky.social, Daniel O'Neil, Johanna D'Addario, Sharon Hall, + Ashita Talsania! ➡️RSVP bit.ly/4sVlvCX

001

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 21/03/2026

Thank you to the presenters and attendees at our inaugural #AI in #Cancer Workshop—highlighting how AI is advancing early detection and enabling more personalized cancer care. A day filled with valuable insights & new collaborations. @williamohmd.bsky.social @maryamlustberg.bsky.social

001

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 22/12/2025

Join us Wednesday, Jan. 28 at 6pm for a free networking and #CME dinner on women's health + #breastcancer. Presenters include Drs. Robert Legare, Anca Bulgaru, Mary Jane Minkin, Jill Banatoski, and @maryamlustberg.bsky.social. ➡️RSVP bit.ly/48QFOcc

021

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 12/12/2025

Ismail Ajjawi @yaleschoolofmed.bsky.social ’27 presents data on premenopausal women with early-stage HR+/HER2– node-negative #breastcancer at #SABCS25 • Chemo use ⬇️ 35%→24% • 72% omitted chemo, w/no difference in 5-yr OS @oncoalert.bsky.social @sabcs.bsky.social @maryamlustberg.bsky.social

031

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 12/12/2025

Drs. Jessica Liu and Guannan Gong present new data #SABCS25 showing automated #ClinicalTrial Patient Matching (CTPM) helps identify diverse trial candidates, but additional strategies are needed to boost participation. @maryamlustberg.bsky.social

031

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 11/12/2025

@maryamlustberg.bsky.social presents #REPOWER at #SABCS25 —an intl study of pts with stage II/III HR+/HER2- early #breastcancer receiving adjuvant ribociclib + endocrine therapy. @oncoalert.bsky.social @sabcs.bsky.social

031

Reposted by Maryam Lustberg MD MPH FASCO

Nicole Casasanta, MD @ncasasanta.bsky.social · 09/12/2025

📌Starting #SABCS25 off with a discussion of the Advanced Breast Cancer (ABC) Global Decade Report 📈 🔸improved 5 year OS 26% ➡️33% 🔸improvement in QOL, but 79% report negative QOL 🔸access to care gaps have widened ✅ 10 goals 2025-2035 #bcsm @maryamlustberg.bsky.social

022

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 09/12/2025

This afternoon at 2:30pm CST/3:30pm EST #SABCS25, @maryamlustberg.bsky.social shares two presentations during Education Session 4: Hormone Replacement Therapy in #BreastCancer Care. sabcs.org/events/educa... @sabcs.bsky.social

052

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 09/12/2025

@maryamlustberg.bsky.social highlights the major unmet needs in #menopause care after #breastcancer at #SABCS25. “Our patients have a lot of symptoms and they are not always being addressed — we need to do a lot better.” @sabcs.bsky.social

0115

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 10/12/2025

Important conversation at #SABCS25 on hormone replacement therapy in breast cancer care with Drs. @lisalarkinmd.bsky.social, Jewel King, Thelma Brown, @maryamlustberg.bsky.social, and Tara Sanft. @theaacr.bsky.social @sabcs.bsky.social

032

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 10/12/2025

@maryamlustberg.bsky.social breaks down key insights on hormone replacement therapy #HRT for #breastcancer survivors at #SABCS25: "We are not the hormone police—our role is to empower patients." @sabcs.bsky.social

032

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 10/12/2025

@maryamlustberg.bsky.social highlights why patient-reported outcomes (PROs) must be central to oncology drug development and clinical trials at #SABCS25: "Partnering with our patients and patient advocacy organizations is the path forward." @sabcs.bsky.social

042

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 11/12/2025

Dr. Guannan Gong shares how an #AI-driven patient-matching system improved ID of eligible patients for #breastcancer trials + increased representation of under-enrolled groups. #SABCS25 @maryamlustberg.bsky.social @sabcs.bsky.social @oncoalert.bsky.social

022

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 10/12/2025

Powerful message from Dr. Amy Beumer at #SABCS25: It’s time to “fix the toxic friendship” and design dosing with patients—balancing side effects, quality of life, and longevity. @maryamlustberg.bsky.social @sabcs.bsky.social

052

Reposted by Maryam Lustberg MD MPH FASCO

San Antonio Breast Cancer Symposium @sabcs.bsky.social · 09/12/2025

Balancing Act: Hormone Replacement Therapy in Breast Cancer Care— Maryam Lustberg, Juliana Kling, Lisa Larkin, & advocate Thelma P. Brown addressed this topic in an #SABCS25 educational session moderated by Tana Sanft. @maryamlustberg.bsky.social @lisalarkinmd.bsky.social @drjewelk.bsky.social

082

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 09/10/2025

The editors of @ascocancer.bsky.social's #JCOOncologyAdvances recently met at the ASCO HQ to discuss strategy and planning for the year ahead. @pamelakunzmd.bsky.social serves as editor-in-chief and she was joined by associate editors, including Yale’s @maryamlustberg.bsky.social.

051

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 19/10/2025

@maryamlustberg.bsky.social shares insights on #breastcancer prevention, treatment, and new research, in honor of #breastcancerawarenessmonth tonight at 7:30pm on #YaleCancerAnswers. 🎧Listen live on WNPR 🔁Download on Apple Podcasts 💻Watch on YouTube

031

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 24/10/2025

Thank you to everyone that joined us Wednesday night at the #SaybrookResortandMarina for an evening of networking and connections around the topic of #womenshealth! @maryamlustberg.bsky.social

021

Reposted by Maryam Lustberg MD MPH FASCO

MASCC @cancercaremascc.bsky.social · 10/11/2025

We’re hosting a webinar for members on “Centering Voices: Best Practices for Engaging People with Lived Experience in Supportive Care in Cancer”. Registration is open to all members. To become a member, click here: mascc.org/join-mascc/ #SuppOnc @maryamlustberg.bsky.social @coffeemommy.bsky.social

052

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 06/10/2025

An empowering + emotional day at our Caring for Metastatic Breast Cancer conference on Saturday. 💗 From groundbreaking research to personal stories of strength, we're reminded: no one faces #MBC alone. #BreastFriendsFund @maryamlustberg.bsky.social

041

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 19/08/2025

In metastatic #breastcancer, sacituzumab govitecan given after trastuzumab deruxtecan was linked to ⬇️ PFS across all subtypes. Real-world data published in #JNCI show differences in outcomes by type. academic.oup.com/jnci/advance... @maryamlustberg.bsky.social

academic.oup.com

Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer

AbstractBackground. Most patients with metastatic breast cancer (MBC) are eligible for treatment with trastuzumab deruxtecan (T-DXd). No data are available

033

Reposted by Maryam Lustberg MD MPH FASCO

MASCC @cancercaremascc.bsky.social · 28/06/2025

A big thank you once again to our dedicated Social Media Ambassadors for 2025: @maryamlustberg.bsky.social @darcyburbage.bsky.social @coffeemommy.bsky.social @bogda-koczwara.bsky.social @stage4kelly.bsky.social Thank you for your insightful posting across the three days of #MASCC25!

282

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 27/06/2025

Congratulations to @maryamlustberg.bsky.social named an inaugural @cancercaremascc.bsky.social Fellow during #mascc25!

052

Reposted by Maryam Lustberg MD MPH FASCO

@doublewhammied @doublewhammied.bsky.social · 27/06/2025

Really appreciated the invite to speak from #MASCC25 and @maryamlustberg.bsky.social What a great conference! Amazing speakers on the #toxicities panel. #supportivecarematters #CanSky #OncoSky #IDSky

181

Reposted by Maryam Lustberg MD MPH FASCO

Stacey Tinianov, MPH @coffeemommy.bsky.social · 26/06/2025

Kudos and gratitude to the organizers, attendees, and fellow faculty members for today's Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment #MASCC25 @maryamlustberg.bsky.social @tingtingzhang.bsky.social @ericroeland.bsky.social @brueraeduardo.bsky.social

1169

Reposted by Maryam Lustberg MD MPH FASCO

TingTing Zhang @tingtingzhang.bsky.social · 26/06/2025

Grateful for the insights and discussions shared with the stellar panelists and engaged audience at #MASCC25 workshop for cancer treatment toxicities. @maryamlustberg.bsky.social @ericroeland.bsky.social @coffeemommy.bsky.social and Dr Eduardo Bruera with screenshot from @stage4kelly.bsky.social

073

Reposted by Maryam Lustberg MD MPH FASCO

MASCC @cancercaremascc.bsky.social · 18/06/2025

Introducing our #MASCC25 Social Media Ambassadors on Bluesky! Follow them for daily highlights from across our scientific program: @maryamlustberg.bsky.social @darcyburbage.bsky.social @coffeemommy.bsky.social @bogda-koczwara.bsky.social @stage4kelly.bsky.social

063

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 01/06/2025

Dr. Melissa Taylor presents data demonstrating the positive impact of ReX, a remote digital nurse app, to ⬇️ medication discontinuation and track #PROs at #ASCO25. meetings.asco.org/abstracts-pr... @maryamlustberg.bsky.social @oncoalert.bsky.social @yaleschoolofmed.bsky.social

041

Reposted by Maryam Lustberg MD MPH FASCO

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · 01/06/2025

@michael-jefford.bsky.social champions an allstar #survonc panel. 20 years from #IOM paper Lost in Transition. So much ground covered, so much yet to go. @oncoalert.bsky.social @weoncologists.bsky.social @pallonccop.bsky.social @fumikochino.bsky.social @maryamlustberg.bsky.social

053

Reposted by Maryam Lustberg MD MPH FASCO

Nicole Casasanta, MD @ncasasanta.bsky.social · 01/06/2025

Inspirational words on positioning yourself for success by these four women physician leaders! Sharing advice with early career women in oncology. Now we have the tools for success🛠️✨#ASCO2025 @maryamlustberg.bsky.social @drgattimays.bsky.social @yalecancer.bsky.social

062

Reposted by Maryam Lustberg MD MPH FASCO

TingTing Zhang @tingtingzhang.bsky.social · 26/05/2025

Join us to discuss patient partnering in managing chronic toxicities of cancer treatment -with increasing burden from newer regimes on patients, doctors, and our healthcare systems. #medsky #palliative #supportivecare #oncosky #cancer #toxicities

197

Reposted by Maryam Lustberg MD MPH FASCO

MASCC @cancercaremascc.bsky.social · 26/05/2025

1/2 Don’t miss our #MASCC25 workshop “Partnering with Patients in Managing Chronic Toxicities of Cancer and Its Treatment”, chaired by @maryamlustberg.bsky.social & @tingtingzhang.bsky.social With presentations from @ericroeland.bsky.social @brueraeduardo.bsky.social and @coffeemommy.bsky.social

1132

Reposted by Maryam Lustberg MD MPH FASCO

Darcy Burbage, DNP, RN, AOCN @darcyburbage.bsky.social · 08/05/2025

Thank you @maryamlustberg.bsky.social for sharing updates from @cancercaremascc.bsky.social to the @pallonccop.bsky.social !! Looking forward to participating/promoting the many great programs and initiatives! #oncsky #oncologynursing

096

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 24/04/2025

A @yalecancer.bsky.social -led study examined chemotherapy-induced peripheral neuropathy #CIPN from clinical presentation, risk factors, + treatment strategies to impact of CIPN on QOL + patient experience. apm.amegroups.org/article/view... @yaleschoolofmed.bsky.social @maryamlustberg.bsky.social

apm.amegroups.org

Chronic chemotherapy-induced peripheral neuropathy: living with neuropathy during and after cancer treatments

011

Reposted by Maryam Lustberg MD MPH FASCO

MASCC @cancercaremascc.bsky.social · 08/04/2025

Watch the recording from our recent webinar: Innovative Approaches in the Management of Bone Metastasis: Enhancing Patient Outcomes Through Safe Exercise, Skeletal-Related Event (SREs) Prevention, and Biosimilars vimeo.com/1071779724?s... #SuppOnc @fatmabenabid.bsky.social

vimeo.com

MASCC Webinar: Innovative Approaches in the Management of Bone Metastasis

Innovative Approaches in the Management of Bone Metastasis: Enhancing Patient Outcomes Through Safe Exercise, Skeletal-Related Event (SREs) Prevention, and Biosimilars Learning…

065

Reposted by Maryam Lustberg MD MPH FASCO

MASCC @cancercaremascc.bsky.social · 16/04/2025

One week left to register for #MASCC25 at the early bird rate! The deadline is April 23, so be sure to register soon to take advantage of the discounted price. mascc.org/annualmeetin... #OncSky @oncoalert.bsky.social @maryamlustberg.bsky.social @andreasc.bsky.social @joannebowen.bsky.social

032

Reposted by Maryam Lustberg MD MPH FASCO

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 15/04/2025

It's my first time going to @cancercaremascc.bsky.social!! Honored to be invited to speak about #financialToxicity and excited to see all of the amazing work being done in #supponc #survonc #pallonc 📆Register by 4/23/2025 to take advantage of the reduced "early bird" price for #MASCC25

SEATTLE
MASCC/ISOO ANNUAL MEETING
JUNE 26-28 SUPPORTIVE CARE IN CANCER
REGISTER TODAY!

3244

Reposted by Maryam Lustberg MD MPH FASCO

MASCC @cancercaremascc.bsky.social · 09/04/2025

The early bird registration deadline is coming up soon! Register by April 23, 2025 to take advantage of the reduced price for #MASCC25 mascc.org/annualmeetin... @oncoalert.bsky.social #OncSky @maryamlustberg.bsky.social @joannebowen.bsky.social @andreasc.bsky.social

034

Reposted by Maryam Lustberg MD MPH FASCO

Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 02/04/2025

Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early #BreastCancer, a discrete choice survey study recently published in the Breast Cancer Research and Treatment journal. 🔓https://pubmed.ncbi.nlm.nih.gov/39915434/ @elmayermd.bsky.social @maryamlustberg.bsky.social

044

Reposted by Maryam Lustberg MD MPH FASCO

Dr. Emily Drake @emilydrake.ca · 19/03/2025

Sounds like a great session @maryamlustberg.bsky.social!

021

Reposted by Maryam Lustberg MD MPH FASCO

Elisabetta Bonzano MD, PhD @elisabettabonzano.bsky.social · 14/03/2025

Oncology HERE & NOW Webcast/Podcast Now Out, JOIN OncoAlert Faulty🚨 Dr. @elisaagostinetto.bsky.social 🇧🇪& Dr. @maryamlustberg.bsky.social 🇺🇸 as they dive into #BreastCancer and the use of adj CDK 4/6 inhibitors and more youtu.be/zw8vYd894jI Podcasts : buzzsprout.com/1324033/epis...

youtu.be

Oncology Here & Now Podcast: Breast Cancer with Dr. Maryam Lustberg & Dr. Elisa Agostinetto

YouTube video by OncoAlert 360

054

Reposted by Maryam Lustberg MD MPH FASCO

Yale Cancer Center @yalecancer.bsky.social · 14/03/2025

Congratulations to @craigmcrews.bsky.social, recipient of the 2025 Passano Award for his work leading to a new class of drugs—the #PROTAC concept—targeting protein degradation to treat #cancer and human diseases. @yaleschoolofmed.bsky.social

194

Maryam Lustberg MD MPH FASCO @maryamlustberg.bsky.social · 08/03/2025

Thank you Infinite Strength & Roberta Lombardi for this wonderful conference #mbc #bcsm

052